The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI

BACKGROUND: Erythropoietin (Epo) has been shown to improve myocardial function in models of experimental myocardial infarction, but has also been associated with a rise in thromboembolic events. Thus, the aim of this study was to investigate the influence of Epo on platelet activation and coagulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Demetz, Gabriele, Laux, Magdalena, Scherhag, Armin, Hoekstra, Tiny, Suttorp, Marit M, Dekker, Friedo, Roest, Mark, Marcus-Kalish, Mira, Mittelman, Moshe, Ott, Ilka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165375/
https://www.ncbi.nlm.nih.gov/pubmed/25228850
http://dx.doi.org/10.1186/1477-9560-12-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165375/
https://www.ncbi.nlm.nih.gov/pubmed/25228850
http://dx.doi.org/10.1186/1477-9560-12-18

Ejemplares similares